ArticleCureus2026
Herpes Zoster Ophthalmicus Complicated by Optic Neuritis: Diagnostic and Therapeutic Challenges.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herpes zoster ophthalmicus (HZO) is caused by reactivation of the varicella-zoster virus (VZV) in the ophthalmic branch of the trigeminal nerve and can result in a range of ocular complications. One of the rare but serious sequelae of HZO is optic neuritis, which can lead to significant visual impairment within a few days without timely management. We present a case of an immunocompetent adolescent female who developed right-sided retrobulbar optic neuritis following an episode of HZO. Her condition was confirmed with magnetic resonance imaging (MRI), which showed optic nerve involvement. Management included intravenous and oral antivirals, along with high-dose corticosteroids, resulting in partial visual recovery. This case underscores the need for heightened clinical suspicion for optic neuritis in patients presenting with HZO, even among young immunocompetent individuals. Prompt and aggressive antiviral and anti-inflammatory treatment, coupled with multidisciplinary management, is crucial for optimal visual outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.